| Ayana Marie Fordham, MA, LCSW | |
|
374th Medical Group, Unit 5071, Apo, AP 96328-5071 | |
| (315) 225-6769 | |
| Not Available |
| Full Name | Ayana Marie Fordham |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 374th Medical Group, Apo, Armed Forces Pacific |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326285156 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6801095972 (Michigan) | Primary |
| Entity Name | Re-connect My Life Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548637143 PECOS PAC ID: 2769725696 Enrollment ID: O20190516002275 |
News Archive
Information flow in cells relies on calcium as a key agent in several signalling pathways. Calcium dependent signalling is crucial in nearly every aspect of life - muscle movement, immune reactions, nerve function, light sensing and many such processes.
Taro Pharmaceutical Industries Ltd. announced that the U.S. Patent and Trademark Office has issued United States Patent No. 7,683,071 covering T2007. The patent, entitled "Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid," is for one of a class of non-sedating barbiturate compounds currently in development by the Company.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
Viatronix Incorporated, a leading innovator and developer of 2D/3D medical imaging and diagnostic software today announced that their V3D-Colon platform was exclusively used to perform a key study recently published in the Annals of Internal Medicine.
Drug giant Pfizer has won a court ruling in the United States which could limit the lawsuits the company might possibly face over claims that its painkiller Celebrex caused heart attacks and strokes.
› Verified 2 days ago
| Entity Name | Mkaddesh Enterprises Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518664069 PECOS PAC ID: 6901130483 Enrollment ID: O20230321000144 |
News Archive
Information flow in cells relies on calcium as a key agent in several signalling pathways. Calcium dependent signalling is crucial in nearly every aspect of life - muscle movement, immune reactions, nerve function, light sensing and many such processes.
Taro Pharmaceutical Industries Ltd. announced that the U.S. Patent and Trademark Office has issued United States Patent No. 7,683,071 covering T2007. The patent, entitled "Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid," is for one of a class of non-sedating barbiturate compounds currently in development by the Company.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
Viatronix Incorporated, a leading innovator and developer of 2D/3D medical imaging and diagnostic software today announced that their V3D-Colon platform was exclusively used to perform a key study recently published in the Annals of Internal Medicine.
Drug giant Pfizer has won a court ruling in the United States which could limit the lawsuits the company might possibly face over claims that its painkiller Celebrex caused heart attacks and strokes.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ayana Marie Fordham, MA, LCSW Unit 5071, Apo, AP 96328-5071 Ph: (315) 225-6769 | Ayana Marie Fordham, MA, LCSW 374th Medical Group, Unit 5071, Apo, AP 96328-5071 Ph: (315) 225-6769 |
News Archive
Information flow in cells relies on calcium as a key agent in several signalling pathways. Calcium dependent signalling is crucial in nearly every aspect of life - muscle movement, immune reactions, nerve function, light sensing and many such processes.
Taro Pharmaceutical Industries Ltd. announced that the U.S. Patent and Trademark Office has issued United States Patent No. 7,683,071 covering T2007. The patent, entitled "Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid," is for one of a class of non-sedating barbiturate compounds currently in development by the Company.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
Viatronix Incorporated, a leading innovator and developer of 2D/3D medical imaging and diagnostic software today announced that their V3D-Colon platform was exclusively used to perform a key study recently published in the Annals of Internal Medicine.
Drug giant Pfizer has won a court ruling in the United States which could limit the lawsuits the company might possibly face over claims that its painkiller Celebrex caused heart attacks and strokes.
› Verified 2 days ago
Mr. David Thomas Powell Jr., LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 35 Mdos/sgow, Unit 5024, Apo, AP 96319 Phone: 811-767-7212 | |
Pamela L Blueford, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 51 Mdg Sgoh, Unit 2060, Apo, AP 96278 Phone: 011-823-16612148 Fax: 011-823-16612630 | |
Emily Hogan, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 374 Mdg, Unit 5071, Apo, AP 96328 Phone: 315-225-7508 | |
Mrs. Ashley Renee Delavega, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Unit 5269, Apo, AP 96368 Phone: 098-961-0433 | |
Cody Ray Sanders, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Unit 15245 Box Brian, Apo, AP 96271 Phone: 210-517-2674 | |
Ms. Young Hee Yoo, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Psc 303, Box 48, Apo, AP 96204 Phone: 822-050-57383880 | |
Min Shin, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: Brian D. Allgood Army Community Hospital (bdaach), Unit 15245, Apo, AP 96273 Phone: 315-737-5799 |